Severe Acute Respiratory Syndrome
Respiratory·MeSH: Severe Acute Respiratory Syndrome
2 drugs in development·2 companies·0 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| paxlovid | PFIZER INC (PFE) |
Phase 3(1)
| Drug | Company |
|---|---|
| nvx-cov2705 vaccine | NOVAVAX INC (NVAX) |
Compare drugs
Deep-dive into Severe Acute Respiratory Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis